ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Press Release
DC Healthcare Rides the Wave of Success with New Openings at Publika and Bukit Indah
Apr 18, 2024 19:33 JST
More info..
DC Healthcare Continues Growth Momentum with Second DC Body Outlet Opening in USJ Taipan
Mar 25, 2024 19:00 JST
DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, continues the Group's growth momentum to announcing the opening of the latest DC Body outlet in USJ Taipan.
More info..
DC Healthcare Further Expands into Perai, Pulau Pinang with Two New Outlets, and Introduces DC Body
Feb 29, 2024 11:20 JST
DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, is pleased to announce the opening of two new outlets: Dr Chong Clinic and DC Body, both located in Perai Pulau Pinang (Auto City).
More info..
DC Healthcare Announces Expansion with New Branches in Johor Bahru and Ipoh
Feb 21, 2024 20:00 JST
DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, is pleased to announce the openings of the Group's new branches in Johor Bahru (Taman Molek), and Ipoh (Bandar Seri Botani).
More info..
DC Healthcare Unveils Innovative Skincare Range 'newB' Under Subsidiary Ten Doctors Sdn Bhd
Nov 01, 2023 19:00 JST
More info..
DC Healthcare Debuts on ACE Market with a Premium of RM0.15 over IPO Price
Jul 17, 2023 11:00 JST
DC Healthcare Holdings Berhad, an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, today debuted on the ACE Market of Bursa Malaysia Securities Berhad, opening at RM0.40 per share representing a premium of 60% over the initial public offering (IPO) price of RM0.25 per share.
More info..
1
Latest Release
Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event
Sep 03, 2025 12:30 JST
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Sep 03, 2025 11:32 JST
Anime Tokyo Station: TV Anime "SPY x FAMILY" Special Exhibition, Period: August 16 - November 9, 2025
Sep 03, 2025 11:00 JST
Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure
Sep 03, 2025 10:58 JST
Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT
Sep 02, 2025 12:50 JST
Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework "SAFe(R)"
Sep 02, 2025 11:50 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Sep 01, 2025 22:28 JST
DENSO Signs Agreement to Transfer Part of Its Ceramic Product Business
Sep 01, 2025 20:52 JST
Honda to Provide Official Vehicles for World Athletics Championships Tokyo 25 as Official Global Partner
Sep 01, 2025 13:50 JST
FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Sep 01, 2025 13:44 JST
TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) - Applications for Research Projects Open on September 1
Sep 01, 2025 11:00 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Aug 29, 2025 20:39 JST
Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building
Aug 29, 2025 18:54 JST
Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma
Aug 29, 2025 18:17 JST
Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage
Aug 29, 2025 15:17 JST
Hong Kong Watch & Clock Fair, Salon de TIME return in September
Aug 28, 2025 21:27 JST
SenseTime Announces 2025 Interim Results
Aug 28, 2025 21:20 JST
Ausnutria 2025 Interim Results Announcement: Revenue and Profit Maintain Resilient Dual Growth
Aug 28, 2025 19:09 JST
Baguio Green Group (1397.HK) Announces 2025 Interim Results
Aug 28, 2025 19:03 JST
Production, Sales and Export Results for July, 2025
Aug 28, 2025 17:36 JST
More Latest Release >>